5 quarters tracked · Beat rate 80% · Updated quarterly
| Period | Report Date | EPS Estimate | EPS Actual | Surprise | Result |
|---|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $6.27 | $7.45 | +18.9% | Beat |
| Q1 2026 | 2026-03-31 | $10.93 | $12.58 | +15.1% | Beat |
| Q4 2025 | 2025-12-31 | $3.13 | $3.33 | +6.5% | Beat |
| Q3 2025 | 2025-09-30 | $4.98 | $6.03 | +21.0% | Beat |
| Q2 2025 | 2025-06-30 | $9.04 | $8.84 | -2.3% | Miss |
Earnings Beat Rate
Elevance Health has beaten analyst EPS estimates in 4 of 5 tracked quarters (80% beat rate). Data sourced from SEC filings and analyst consensus. View full AI analysis →